共 85 条
[1]
Yanagisawa S(2018)Definition and diagnosis of asthma-COPD overlap (ACO) Allergol Int 67 172-178
[2]
Ichinose M(2016)What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion Eur Respir J 48 664-673
[3]
Sin DD(2018)Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial Lancet Respir Med 6 747-758
[4]
Miravitlles M(2018)Triple therapy trials in COPD: a precision medicine opportunity Eur Respir J 52 1801848-3981
[5]
Mannino DM(2018)Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal Int J Chron Obstruct Pulmon Dis 13 3971-160
[6]
Soriano JB(2020)Exacerbation benefit by blood eosinophil counts with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial: a subgroup analysis Eur Respir J 56 984-S17
[7]
Price D(2018)Late breaking abstract—impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis) Eur Respir J 52 PA688-1724
[8]
Celli BR(2004)Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease Proc Am Thorac Soc 1 152-189
[9]
Ferguson GT(2001)Reference values for spirogram and blood gas analysis in Japanese adults J Jpn Respir Soc 39 S1-632
[10]
Rabe KF(2018)Making sense of triple inhaled therapy for COPD N Engl J Med 378 1723-664